Cryo-Cell
Update in progressCCEL (NYSE American)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Care Facilities
Cryo-Cell International, Inc. provides cord blood and cord tissue cryopreservation services in the United States. It offers cellular processing and long-term cryogenic storage for family use and for public use. The company also manufactures PrepaCyte CB processing systems and provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets to expectant parents and through clinicians. Established 1989, based in Oldsmar, Florida.
Company score
- Sentiment
- -0.49
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.22
- Governance
- -0.38
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.15
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.32
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!